Straits Times Index
3,227.10 -35.97 (-1.10%) Nikkei
27,153.83 -159.30 (-0.58%) Hang Seng
17,933.27 -214.68 (-1.18%) FTSE 100
7,018.60 -140.92 (-1.97%) BTC-USD
19,079.52 +336.48 (+1.80%) CMC Crypto 200
434.61 -9.92 (-2.23%)
Amyris, Inc. (AMRS)
After hours:
| Previous close | 3.2200 |
| Open | 3.3400 |
| Bid | 2.9900 x 2200 |
| Ask | 3.0500 x 4000 |
| Day's range | 2.9600 - 3.1700 |
| 52-week range | 1.4700 - 15.1200 |
| Volume | |
| Avg. volume | 7,345,393 |
| Market cap | 987.574M |
| Beta (5Y monthly) | 1.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3870 |
| Earnings date | 07 Nov 2022 - 11 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
3 Stocks That Can Double Your Money According to Wall Street
Analysts working at Wall Street investment banks have some stocks in mind that have fallen on hard times but still have a chance to succeed. Ginkgo Bioworks (NYSE: DNA) and its mission to do fun stuff with DNA excited early investors in 2021. Unfortunately, the company manages custom-built organisms much better than it handles its cash flows.
- Motley Fool
Amyris (AMRS) Q2 2022 Earnings Call Transcript
This call is being webcast live on the events page of the investor section of the Amyris' website at amyris.com. You may listen to a webcast replay of this call by going to the investor section of Amyris' website. With me on today's call are John Melo, president and chief executive officer; and also Eduardo Alvarez, chief operating officer to support our Q&A session today.
- Zacks
Amyris, Inc. (AMRS) Reports Q2 Loss, Lags Revenue Estimates
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -50% and 20.06%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
